Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

FDA approval for Novartis' melanoma combo

pharmatimesJuly 12, 2018

Tag: metastatic melanoma , Novartis , FDA

PharmaSources Customer Service